29
February 2024
Welcia-Tsuruha merger sparks drugstore industry reorganization: A major alliance worth 2 trillion yen in [annual] sales is born
Yomiuri Shimbun
29
February 2024
Tsuruha Holdings to become part of Aeon and merge with Welcia Holdings by end of 2027
Hokkaido Shimbun
29
February 2024
Competition Intensifies: Restructuring looms closer – Tsuruha to become part of Aeon – Trigger for talks with ‘activist shareholder’
Hokkaido Shimbun
28
February 2024
JAE share price down by 3% due to continued selling following the rejection of Oasis’ injunction over soon-to-expire tender offer
Nikkei QUICK News
28
February 2024
Japan retailer Aeon to merge with drugstore chains Tsuruha and Welcia
Reuters
27
February 2024
Hazama Ando tops expected dividends ranking despite decrease in net profit – Financial Results Ranking (#2): Expected dividend yields for the fiscal year ending March 31, 2024
The Nikkei
27
February 2024
The Present and Future of Governance – Tokyo Disney operator’s shares targeted again; Mitsui Fudosan invests as part of its ‘core business’
Nikkei Business
26
February 2024
Fund files injunction against NEC’s sale of subsidiary shares
The Nikkei
26
February 2024
Tsuruha HD shares temporarily up 14% on possibility of merger with Welcia HD
The Nikkei
26
February 2024
Hong Kong investor files court injunction on NEC’s JAE stake sale
Reuters
26
February 2024
Oasis files injunction to stop NEC from tendering shares as part of JAE buyback
Reuters Japan
26
February 2024
Oasis files injunction against NEC’s application to JAE tender offer
Bloomberg Japan
26
February 2024
Tsuruha and Welcia merger being considered: With Aeon as a shareholder, the resulting company would become Japan’s 4th-largest retailer
Hokkaido Shimbun
25
February 2024
Drugstores becoming increasingly ‘mega-sized’: Welcia x Tsuruha merger under consideration; resulting company would be Japan’s 4th-largest retailer
The Nikkei
12
February 2024
Oasis says it opposes Taisho Pharma’s $5bln management buyout
Reuters
12
February 2024
Oasis opposes Taisho Pharmaceutical MBO, says price is ‘too low’
Reuters Japan
07
February 2024
More global activists than ever before, particularly at Japanese and European companies
The Nikkei
02
February 2024
Retail reshuffling reflects shrinking domestic consumption
The Nikkei
31
January 2024
Aeon Co. leads retail restructuring: industry to witness birth of drugstore coalition worth ¥2 trillion in annual sales amid [Aeon’s] acquisition of Tsuruha shares, increasing stake to more than 25%
The Nikkei
30
January 2024
Aeon to increase its stake in Tsuruha to 26%, negotiating with Hong Kong fund to potentially create major alliance
Hokkaido Shimbun
30
January 2024
Aeon to buy more Tsuruha shares, negotiating with fund in hopes of creating giant drugstore alliance
The Nikkei
29
January 2024
Aeon negotiating to acquire shares in Tsuruha, which together with industry leader Welcia would bring total [annual] sales to more than 2 trillion yen… will there be an industry reorganization?
Yomiuri Shimbun
29
January 2024
Aeon begins exclusive negotiations with Oasis for acquisitions of Tsuruha shares
Reuters
29
January 2024
Japan’s Aeon in exclusive talks to buy Tsuruha stake from Oasis
Reuters
26
January 2024
As China’s markets stumble, Japan rises toward record
New York Times
24
January 2024
Activist shareholders triple presence in 5 years, following Japanese firms’ P/B ratio reforms
The Nikkei
16
January 2024
Fujitec to announce new medium-term management plan in May, following management changes
The Nikkei
16
January 2024
Oasis Management submits large shareholding report for stake in Shidax Corporation
M&A Online
04
January 2024
Tender offer for Itochu subsidiary causes another stir: Another chance for Oasis
Senkaku
04
January 2024
Are the ‘black ships’ friend or foe? The companies entrusting activists to serve on their boards of directors
Asahi Shimbun